NMR - Nomura Holdings, Inc.
NYSE
->
Financial Services
->
Capital Markets
Tokyo,
Japan
Type: Equity
NMR price evolution
NMR
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $1509016 | $1391315 | ||
| Inventory | ||||
| Total current assets | $6131816 | $5813259 | ||
| Long term investments | ||||
| Property, plant & equipment | $466800 | $462873 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $54752735 | $54815293 | ||
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $28841849 | $28681567 | ||
| Long term debt | $11805442 | $11442058 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $51473211 | $51523853 | ||
| Shareholders' equity | ||||
| Retained earnings | $1693511 | $1642918 | ||
| Other shareholder equity | $370507 | $442562 | ||
| Total shareholder equity | ||||
| (in millions $) | 1 May 2023 | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3316238 | $3509754 | $3191889 | |
| Short term investments | $17302960 | $16412997 | $16280798 | |
| Net receivables | $1193342 | $5000702 | $4142447 | $5116913 |
| Inventory | ||||
| Total current assets | $5714589 | $41171471 | $40020974 | $41769057 |
| Long term investments | $1048052 | $981625 | $1121341 | |
| Property, plant & equipment | $464316 | $419047 | $464449 | $440512 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $47771802 | $43412156 | $42516480 | $43999815 |
| Current liabilities | ||||
| Accounts payable | $3159686 | $3228454 | $3120929 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $22080639 | $28003852 | $28810871 | $30918766 |
| Long term debt | $10399210 | $9654597 | $8367527 | $8493376 |
| Total noncurrent liabilities | $164013.8 | $150161.9 | ||
| Total debt | $221050.34 | $272439.68 | ||
| Total liabilities | $44623235 | $40439353 | $39760029 | $41268551 |
| Shareholders' equity | ||||
| Retained earnings | $1647005 | $1606987 | $1533713 | $1645451 |
| Other shareholder equity | $318454 | $127973 | -$38144 | -$26105 |
| Total shareholder equity | $2914605 | $2694938 | $2653467 | |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1080487 | $1012700 | ||
| Cost of revenue | ||||
| Gross Profit | $400225 | $367760 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $321514 | $311025 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $26573 | $21150 | ||
| Interest expense | ||||
| Net income | ||||
| Net income | $50550 | $35232 | ||
| Income (for common shares) | ||||
| (in millions $) | 1 May 2023 | 1 May 2022 | 30 Mar 2021 | 30 Mar 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2486726 | $1401872 | $1285829 | |
| Cost of revenue | $290385 | $276440 | ||
| Gross Profit | $1335577 | $1111487 | $1009389 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $593793 | $579901 | ||
| Total operating expenses | $1186103 | $1171201 | $1035178 | |
| Operating income | $230671 | $250651 | ||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $57798 | $70274 | $28894 | |
| Interest expense | $2024.41 | $6114.81 | ||
| Net income | ||||
| Net income | $92786 | $153116 | $216998 | |
| Income (for common shares) | $153116 | $216998 | ||
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$740058 | -$61216 | -$11514 | $38945 |
| Financing activities | ||||
| Dividends paid | -$60164 | -$36049 | -$36049 | -$57262 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $582118 | $293768 | -$209224 | $1291697 |
| Effect of exchange rate | $93708 | $199672 | $139530 | $148552 |
| Change in cash and equivalents | $516416 | $284415 | $230985 | $504444 |
| (in millions $) | 1 May 2023 | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 |
|---|---|---|---|---|
| Net income | $142996 | $153116 | $216998 | |
| Operating activities | ||||
| Depreciation | $59524 | $63846 | $65245 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$1368710 | $665770 | -$15943 | |
| Investing activities | ||||
| Capital expenditures | -$111331 | -$119875 | -$206745 | |
| Investments | $54874 | $35729 | $171763 | |
| Total cash flows from investing | $38945 | -$45301 | -$139026 | $216336 |
| Financing activities | ||||
| Dividends paid | -$57262 | -$70714 | -$76358 | -$58416 |
| Sale and purchase of stock | ||||
| Net borrowings | $749444 | -$326207 | $617844 | |
| Total cash flows from financing | $1291697 | $1070715 | -$269927 | $332062 |
| Effect of exchange rate | $148552 | $149693 | $60884 | -$27277 |
| Change in cash and equivalents | $504444 | -$193603 | $317701 | $505178 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |